伊匹单抗-话题@MedSci - williamhill asia

#伊匹单抗#

2篇内容 | 1555人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2178612, encodeId=e5bd21e86125b, content=<a href='/topic/show?id=597725653fd' target=_blank style='color:#2F92EE;'>#伊匹单抗#</a> <a href='/topic/show?id=d1559341310' target=_blank style='color:#2F92EE;'>#转移性尿路上皮癌#</a> <a href='/topic/show?id=fc2be734870' target=_blank style='color:#2F92EE;'>#纳武利尤单抗#</a>, objectTitle=读书报告 | TITAN-TCC研究：含铂化疗后进展的尿路上皮癌患者接受定制的纳武利尤单抗联合伊匹木单抗免疫治疗的II期临床试验, objectType=article, longId=807722, objectId=92ce80e72221, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=92ce80e72221, replyNumber=0, likeNumber=118, createdTime=2024-01-01, rootId=0, userName=williamhill asia 管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=92ce80e72221, moduleTitle=读书报告 | TITAN-TCC研究：含铂化疗后进展的尿路上皮癌患者接受定制的纳武利尤单抗联合伊匹木单抗免疫治疗的II期临床试验, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=92ce80e72221)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2111059, encodeId=50f6211105922, content=瘤内<a href='/topic/show?id=d17466492d5' target=_blank style='color:#2F92EE;'>#溶瘤病毒#</a>V937加<a href='/topic/show?id=597725653fd' target=_blank style='color:#2F92EE;'>#伊匹单抗#</a>治疗晚期<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a>的疗效，仍然从黑色素瘤入手，这是明智的。, objectTitle=J Immunother Cancer：瘤内溶瘤病毒V937加伊匹木单抗治疗晚期黑色素瘤的疗效, objectType=article, longId=756232, objectId=f243e56232e8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221121/1669073265617_4754896.webp, objectUrl=/article/show_article.do?id=f243e56232e8, replyNumber=0, likeNumber=99, createdTime=2023-01-21, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f243e56232e8, moduleTitle=J Immunother Cancer：瘤内溶瘤病毒V937加伊匹木单抗治疗晚期黑色素瘤的疗效, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f243e56232e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=887715, encodeId=953d88e71578, content=<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a><a href='/topic/show?id=597725653fd' target=_blank style='color:#2F92EE;'>#伊匹单抗#</a><a href='/topic/show?id=4e9ae7349f2' target=_blank style='color:#2F92EE;'>#纳武单抗#</a>联合可能更好, objectTitle=Lancet oncol：纳武单抗 vs 伊匹单抗作为高危黑色素瘤术后辅助治疗的4年随访结果！, objectType=article, longId=201125, objectId=c5a52011256e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020923/1600850266428_2110107.PNG, objectUrl=/article/show_article.do?id=c5a52011256e, replyNumber=0, likeNumber=260, createdTime=2020-09-23, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5a52011256e, moduleTitle=Lancet oncol：纳武单抗 vs 伊匹单抗作为高危黑色素瘤术后辅助治疗的4年随访结果！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c5a52011256e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

伊匹单抗

2020-05-29

williamhill asia 管理员 (审核中...)

前往app查看评论内容

#伊匹单抗# #转移性尿路上皮癌# #纳武利尤单抗#

读书报告 | TITAN-TCC研究：含铂化疗后进展的尿路上皮癌患者接受定制的纳武利尤单抗联合伊匹木单抗免疫治疗的II期临床试验

2024-01-01发表于上海

showtest (审核中...)

前往app查看评论内容

瘤内#溶瘤病毒#V937加#伊匹单抗#治疗晚期#黑色素瘤#的疗效，仍然从黑色素瘤入手，这是明智的。

J Immunother Cancer：瘤内溶瘤病毒V937加伊匹木单抗治疗晚期黑色素瘤的疗效

2023-01-21发表于上海

lovetcm (审核中...)

前往app查看评论内容

#黑色素瘤##伊匹单抗##纳武单抗#联合可能更好

Lancet oncol：纳武单抗 vs 伊匹单抗作为高危黑色素瘤术后辅助治疗的4年随访结果！

2020-09-23

科室
- - 订阅+
  - 更多科室
工具
服务